Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 4—April 2006

Pulmonary Tuberculosis and SARS, China

Wei Liu*, Arnaud Fontanet†, Pan-He Zhang*, Lin Zhan*, Zhong-Tao Xin‡, Fang Tang*, Laurence Baril†, and Wu-Chun Cao*Comments to Author 
Author affiliations: *Beijing Institute of Microbiology and Epidemiology, Beijing, People's Republic of China,; †Institut Pasteur, Paris, France; ‡Beijing Institute of Basic Medical Sciences, Beijing, People's Republic of China

Main Article


Demographic and clinical information on severe acute respiratory syndrome (SARS) patients with pulmonary tuberculosis (TB), Beijing, China, 2003

Demographic/clinical characteristic Patient 1 Patient 2 Patient 3
Sex M M M
Age (y) 48 18 20
Other coexisting conditions Pseudomonas aeruginosa infection None None
Date of SARS onset Apr 5, 2003 Apr 7, 2003 Apr 4, 2003
Date of TB diagnosis Jun 12, 2003 Jan 24, 2003 Mar 5, 2003
Date of hospitalization or transfer to SARS ward Apr 7, 2003 Apr 7, 2003 Apr 5, 2003
Leukocyte count at admission, /μL 12,500 6,800 2,500
Total steroid dose used, mg 25,280 2,600 3,600
Intensive care unit admission Yes No No
CD4/CD8 cell ratio 6 mo after disease 0.63 1.56 1.23
Absolute CD4 cell count 6 mo after disease, /μL 368 431 306
Absolute lymphocyte count 6 mo after disease, /μL 2,098 1,115 1,666

Main Article

Page created: January 23, 2012
Page updated: January 23, 2012
Page reviewed: January 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.